Diphenylphosphinsaeurecyanid | 4669-69-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Diphenylphosphinsaeurecyanid
• 英文别名: Diphenylphosphinic cyanide；diphenylphosphorylformonitrile
• CAS: 4669-69-6
• 化学式: C₁₃H₁₀NOP
• 分子量: 227.202
• InChiKey: XKNOLTAFGYHTDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Diphenylphosphinsaeurecyanid 在 18-冠醚-6 potassium cyanide 、 正丁基锂 、 二异丙胺 作用下， 以 四氢呋喃 、 正己烷 、 乙腈 为溶剂， 反应 8.0h， 生成 O-(Diphenylphosphinoyl)-acetophenon-cyanhydrin
  参考文献：
  名称：

  Horner, L.; Gehring, R., Phosphorus and Sulfur and the Related Elements, 1981, vol. 12, p. 75 - 88

  摘要：

  DOI：
• 作为产物：
  描述：

  溴化氰 、 丁基二苯基亚膦酸 以 苯 为溶剂， 以79%的产率得到Diphenylphosphinsaeurecyanid
  参考文献：
  名称：

  Horner, L; Gehring, R., Phosphorus and Sulfur and the Related Elements, 1981, vol. 11, p. 157 - 176

  摘要：

  DOI：

文献信息

• Radical Cyanation of Alkyl Iodides with Diethylphosphoryl Cyanide
  作者：Sunggak Kim、Chang Cho、Jin Lee

  DOI：10.1055/s-0028-1087385

  日期：——

  The β-elimination of an organophosphoryl group from an iminyl radical is observed for the first time. On the basis of this finding, radical cyanation of alkyl iodides is achieved by using diethylphosphoryl cyanide.

  首次观察到来自亚胺基自由基的含磷有机物β-消除反应。基于这一发现，通过使用二乙基磷酰基氰化物，实现了烷基碘的自由基氰化反应。
• Compounds exhibiting thrombopoietin-like activities
  申请人：——

  公开号：US20030162724A1

  公开（公告）日：2003-08-28

  The compounds of the invention are compounds represented by the following general formula (1): 1 wherein E represents one selected from the group consisting of a methylidyne group and a nitrilo group, R 1 represents one selected from the group consisting of optionally substituted aryl groups and optionally substituted heteroaryl groups, R 2 represents one selected from the group consisting of a hydrogen atom and alkyl groups, W 1 represents an amino acid residue, A represents one selected from the group consisting of a carbonyl group and a sulfonyl group, X 1 represents one selected from the group consisting of optionally substituted alkylene groups and optionally substituted alkenylene groups, and p represents 0 or 1; and their pharmacologically acceptable salts, which exhibit thrombopoietin-like activity.

  本发明的化合物是由以下一般式（1）表示的化合物：其中E代表从甲基亚基团和硝基亚基团组成的群体中选择的一种，R1代表从可选择的取代芳基和可选择的取代杂环烷基组成的群体中选择的一种，R2代表从氢原子和烷基组成的群体中选择的一种，W1代表氨基酸残基，A代表从羰基和磺酰基组成的群体中选择的一种，X1代表从可选择的取代烷基烯基团和可选择的取代烯基烷基团组成的群体中选择的一种，p代表0或1；以及它们的药理学上可接受的盐，具有类似于血小板生成素的活性。
• Preparation of substituted quinazolines
  申请人：——

  公开号：US20040158065A1

  公开（公告）日：2004-08-12

  Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis. The disclosed methods employ protecting schemes to minimize undesirable diacryloylamino-quinazoline side products. 1

  揭示了制备一般化合物1的酪氨酸激酶不可逆抑制剂的方法和材料。这些抑制剂包括N-[4-(3-氯-4-氟苯胺基)-7-(3-吗啉-4-基-丙氧基)-喹唑啉-6-基]-丙烯酰胺，可用于治疗癌症、再狭窄、动脉粥样硬化、子宫内膜异位症和牛皮癣。揭示的方法采用保护方案以减少不良的双丙烯酰胺基喹唑啉副产物。
• [EN] PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES<br/>[FR] PRÉPARATION DE 4,5-DIHYDROPYRROLO[4,3,2-DE][2,6]NAPHTYRIDIN-3(1H)-ONES SUBSTITUÉES
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2012078802A1

  公开（公告）日：2012-06-14

  Disclosed are materials and methods for preparing substituted 4,5-dihydropyrrolo[4,3,2-de][2,6]naphthyridin-3(1H)-ones of formula (1), Compounds of formula (1) inhibit one or more members of the Janus Kinase (JAK) family of cytoplasmic protein tyrosine kinases, and are useful for treating disorders, diseases, and conditions associated with the immune system, inflammation, and abnormal cell growth.

  本文揭示了用于制备式（1）的取代4,5-二氢吡咯[4,3,2-de][2,6]萘啶-3(1H)-酮的材料和方法。式（1）的化合物抑制一种或多种丝裂原激酶（JAK）家族的胞质蛋白酪氨酸激酶，并可用于治疗与免疫系统、炎症和异常细胞生长相关的疾病、疾患和情况。
• Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein
  申请人：Herrinton Paul Matthew

  公开号：US20080194841A1

  公开（公告）日：2008-08-14

  Disclosed are materials and methods for preparing optically active β-amino acids, which bind to the alpha-2-delta subunit of a calcium channel and are useful for treating pain, fibromyalgia, and a variety of psychiatric and sleep disorders. The method includes reacting a chiral allyl amine with a 2-alkynoate in the presence of a Lewis acid and a base to give a chiral tertiary enamine, which after reaction with ammonia, is hydrogenated to give optically active β-amino acids.

  本发明涉及制备光学活性β-氨基酸的材料和方法，该氨基酸与钙通道的α-2-δ亚单位结合，并且用于治疗疼痛、纤维肌痛和各种精神和睡眠障碍。该方法包括在路易斯酸和碱的存在下，将手性丙烯基胺与2-炔酸酯反应，得到手性三级恩酰胺，然后与氨反应后，经过氢化作用得到光学活性β-氨基酸。